Bolt Biotherapeutics, Inc. SEC filings BOLT
Bolt Biotherapeutics, Inc. has 294 filings in SEC EDGAR's recent list, going back to May 7, 2015. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 23, 2026 (material agreement, agreement ended, acquisition or sale of assets, unregistered share sale, officer or director change, bylaw or fiscal year change, regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Oct 23, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 6, 2026 | Oct 1, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 11, 2026 |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Apr 27, 2026 |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Other events
|
Oct 2, 2025 | Oct 1, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Listing notice, Bylaw or fiscal year change
|
Jun 6, 2025 | Jun 6, 2025 |
| 8-K |
Current report
Other events
|
Jun 4, 2025 | Jun 4, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 28, 2025 | May 27, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 25, 2025 | May 27, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 16, 2025 | Apr 15, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2025 | May 27, 2025 |
| DEF 14A | Proxy statement | Apr 15, 2025 | May 27, 2025 |
| S-8 | Employee stock plan registration | Mar 24, 2025 | — |
| 10-K | Annual report | Mar 24, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 3, 2025 | Jan 2, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2024 | Dec 23, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 4, 2024 | Aug 28, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Listing notice
|
Jul 3, 2024 | Jul 2, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2024 | Jun 12, 2024 |
| DEFA14A | Additional proxy material | May 20, 2024 | — |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Acquisition or sale of assets, Exit or restructuring costs, Officer or director change
|
May 14, 2024 | May 13, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 12, 2024 |
| S-8 | Employee stock plan registration | Mar 21, 2024 | — |
| 10-K | Annual report | Mar 21, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2024 | Mar 21, 2024 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Aug 7, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2023 | Jun 12, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 12, 2023 |
| S-8 | Employee stock plan registration | Mar 29, 2023 | — |
| 10-K | Annual report | Mar 29, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 29, 2023 | Mar 29, 2023 |
| 8-K |
Current report
Officer or director change
|
Dec 14, 2022 | Dec 14, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 10-Q | Quarterly report | Aug 10, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2022 | Aug 10, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 10, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 10, 2022 |
| EFFECT | Filing | Apr 7, 2022 | — |
| 424B5 | Prospectus supplement | Apr 7, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 6, 2022 | — |
| CORRESP | Letter to the SEC | Apr 5, 2022 | — |
| S-3 | Shelf registration | Mar 30, 2022 | — |
| S-8 | Employee stock plan registration | Mar 30, 2022 | — |
| 10-K | Annual report | Mar 30, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 4, 2022 | Mar 1, 2022 |
| 8-K |
Current report
Material agreement
|
Jan 25, 2022 | Jan 25, 2022 |
| 8-K |
Current report
Officer or director change
|
Dec 16, 2021 | Dec 13, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 6, 2021 | Dec 6, 2021 |
| 8-K |
Current report
Officer or director change
|
Nov 19, 2021 | Nov 15, 2021 |
| 10-Q | Quarterly report | Nov 9, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| D | Filing | Jun 7, 2021 | — |
| 8-K |
Current report
Other events
|
Jun 2, 2021 | Jun 2, 2021 |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2021 | Mar 31, 2021 |
| 10-K | Annual report | Mar 31, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Feb 9, 2021 | Feb 9, 2021 |
| S-8 | Employee stock plan registration | Feb 5, 2021 | — |
| 424B4 | Prospectus | Feb 5, 2021 | — |
| EFFECT | Filing | Feb 4, 2021 | — |
| S-1MEF | Filing | Feb 4, 2021 | — |
| CERT | Filing | Feb 4, 2021 | — |
| SEC STAFF LETTER | Filing | Feb 3, 2021 | — |
| S-1/A | Amended registration statement | Feb 3, 2021 | — |
| CORRESP | Letter to the SEC | Feb 2, 2021 | — |
| CORRESP | Letter to the SEC | Feb 2, 2021 | — |
| 8-A12B | Filing | Feb 2, 2021 | — |
| S-1/A | Amended registration statement | Feb 1, 2021 | — |
| D | Filing | Jan 28, 2021 | — |
| CORRESP | Letter to the SEC | Jan 25, 2021 | — |
| S-1 | Registration statement | Jan 15, 2021 | — |
| DRSLTR | Filing | Jan 11, 2021 | — |
| DRS/A | Filing | Jan 11, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2020 | — |
| SEC STAFF LETTER | Filing | Sep 15, 2020 | — |
| DRS/A | Filing | Sep 11, 2020 | — |
| DRSLTR | Filing | Sep 10, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 1, 2020 | — |
| DRS | Filing | Aug 10, 2020 | — |
| D | Filing | Jul 15, 2019 | — |
| D | Filing | Aug 6, 2018 | — |
| D | Filing | Feb 20, 2018 | — |
| D | Filing | Sep 30, 2016 | — |
| D | Filing | May 7, 2015 | — |
Showing 123 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BOLT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Redwood City, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1641281
- Former names
- Bolt Therapeutics, Inc. (until May 7, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.